First Drug Device Combination of Its Kind for Chronic Wound Care Sarasota, FL, September 2, 2021 — Omeza, a skin science company, announced today the U.S. Food and Drug Administration (FDA) cleared Omeza® Collagen Matrix through the FDA 510(k) premarket notification process. Omeza® Collagen Matrix is Omeza’s first Rx product, and the first drug/device combination…
